All the mutations that are fit to die
Related Experiment Video
Updated: Jul 2, 2025

Analysis of Apoptosis in Zebrafish Embryos by Whole-mount Immunofluorescence to Detect Activated Caspase 3
Published on: December 20, 2013
Emma Gebauer1, Markus A Seeliger1
1Laufer Center for Physical & Quantitative Biology, Department of Pharmacological Sciences, School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
Abstract:
In this issue of Cell Chemical Biology, Chakraborty et al.1 employ a deep mutational screening analysis of 3,500 single point mutations in every residue in Src kinase's catalytic domain to determine which residues are critical for conferring ATP-competitive inhibitor resistance. They identify a dynamically controlled resistance site.
Insights
Researchers identified key mutations in Src kinase that confer resistance to ATP-competitive inhibitors. This deep mutational screening reveals a dynamically controlled site crucial for drug resistance in cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Src kinase is a critical target for ATP-competitive inhibitors in cancer therapy.
- Understanding resistance mechanisms is essential for developing effective cancer treatments.
Purpose of the Study:
- To identify specific residues within the Src kinase catalytic domain that confer resistance to ATP-competitive inhibitors.
- To uncover the mechanisms underlying inhibitor resistance.
Main Methods:
- Deep mutational screening of 3,500 single point mutations across the entire Src kinase catalytic domain.
- Analysis of mutation effects on inhibitor binding and kinase activity.
Main Results:
- Identification of a dynamically controlled resistance site within the Src kinase catalytic domain.
- Specific mutations at this site significantly confer resistance to ATP-competitive inhibitors.
Conclusions:
- The identified resistance site is a key determinant of inhibitor efficacy.
- Targeting this dynamically controlled site may overcome resistance mechanisms in Src-driven cancers.
Related Concept Videos
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
In-vitro Mutagenesis
Mutations

